News + Publications

News
Siolta Therapeutics is Awarded a Phase I SBIR to Develop an LBP for Prevention of Necrotizing Enterocolitis
August 8, 2023
Read More
News
Siolta Therapeutics is Awarded a $3M Phase II SBIR to Advance Innovative Anaerobic Biotherapeutic Manufacturing
November 10, 2021
Read More
News
ADORED Study Update: Final Trial Participant Completes the ADORED Study. Day 672 Readout is Expected in Q1 2026.
November 13, 2025
Read More
News
Siolta Therapeutics is Awarded a $1.8M Phase II SBIR to Develop a Live Biotherapeutic for Recurrent Bacterial Vaginosis
September 10, 2025
Read More
News
Dr. Ricardo Valladares Discusses Infant Microbiome and Allergy Links with Alba Health
July 2, 2025
Read More
News
Siolta Therapeutics and Cowellnex Enter Joint Research Agreement
January 29, 2025
Read More
See All

Events + Conferences

Upcoming Event
November 17, 2025 - , Food Allergy Fund Leadership Forum
Dr. Nikole Kimes Joins the Food Allergy Fund Leadership Forum to Discuss Approaches to Accelerate Innovative Solutions for Food Allergy
Learn More
Event
November 20 - 21, 2024Microbiome Connect Conference
Dr. Ricardo Valladares Presents Data on Live Biotherapeutic Development for Necrotizing Enterocolitis at Microbiome Connect
Learn More
Event
March 18 - 19, 2025Microbiome Times Partnering Forum
Dr. Nikole Kimes Joins the Microbiome Times Partnering Forum Opening Panel: The Present and Future of the Microbiome Industry
Learn More
See All